APA (7th ed.) Citation

YJ, K., T, T., GR, A., JM, P., & DC, B. (2020). Inhibition of BCL2 Family Members Increases the Efficacy of Copper Chelation in BRAFV600E-Driven Melanoma. Cancer research, 80(7), 1387. https://doi.org/10.1158/0008-5472.CAN-19-1784

Chicago Style (17th ed.) Citation

YJ, Kim, Tsang T, Anderson GR, Posimo JM, and Brady DC. "Inhibition of BCL2 Family Members Increases the Efficacy of Copper Chelation in BRAFV600E-Driven Melanoma." Cancer Research 80, no. 7 (2020): 1387. https://doi.org/10.1158/0008-5472.CAN-19-1784.

MLA (9th ed.) Citation

YJ, Kim, et al. "Inhibition of BCL2 Family Members Increases the Efficacy of Copper Chelation in BRAFV600E-Driven Melanoma." Cancer Research, vol. 80, no. 7, 2020, p. 1387, https://doi.org/10.1158/0008-5472.CAN-19-1784.